Position in JNJ
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$3,249,038
-$712,601 QoQ
Shares Held
12,793
-21.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#1,942
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gilman Hill Asset Management, LLC holds $40,633,070 across 8 Drug Manufacturers - General names. JNJ ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
231,255 | $13,324,913 | |
| 2 | PFE |
Pfizer Inc
|
428,237 | $10,311,946 | |
| 3 | GSK |
GSK plc
|
128,768 | $6,750,018 | |
| 4 | ABBV |
AbbVie Inc.
|
13,594 | $3,420,794 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
12,793 | $3,249,038 | |
| 6 | LLY |
ELI LILLY & Co
|
1,606 | $1,926,284 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,457 | $1,343,724 | |
| 8 | AMGN |
Amgen Inc
|
846 | $306,353 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,249,038 | 12,793 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $3,961,639 | 16,207 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $3,208,138 | 15,502 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $2,831,363 | 15,270 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,334,631 | 15,284 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,723,756 | 16,424 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,550,229 | 17,634 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $2,324,102 | 14,341 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,775,259 | 12,146 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $2,254,998 | 14,255 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $2,478,843 | 15,815 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,977,713 | 12,698 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $2,263,817 | 13,677 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,263,000 | 14,600 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $2,618,659 | 14,824 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,926,667 | 11,794 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $2,121,777 | 11,953 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,747,665 | 9,861 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $1,602,241 | 9,366 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,538,287 | 9,525 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $1,426,318 | 8,658 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $1,125,140 | 6,846 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $1,170,277 | 7,436 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,050,050 | 7,053 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $1,000,301 | 7,113 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $893,257 | 6,812 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||